139 related articles for article (PubMed ID: 21094583)
21. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
[TBL] [Abstract][Full Text] [Related]
23. Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
Yasuda M; Mizukami M; Hanagiri T; Shigematsu Y; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(5A):3607-11. PubMed ID: 17094490
[TBL] [Abstract][Full Text] [Related]
24. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
25. Immunomic analysis of human sarcoma.
Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
[TBL] [Abstract][Full Text] [Related]
26. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
Okada T; Akada M; Fujita T; Iwata T; Goto Y; Kido K; Okada T; Matsuzaki Y; Kobayashi K; Matsuno S; Sunamura M; Kawakami Y
Clin Cancer Res; 2006 Jan; 12(1):191-7. PubMed ID: 16397042
[TBL] [Abstract][Full Text] [Related]
27. Head and neck cancer antigens recognized by the humoral immune system.
Monji M; Senju S; Nakatsura T; Yamada K; Sawatsubashi M; Inokuchi A; Nishimura Y
Biochem Biophys Res Commun; 2002 Jun; 294(3):734-41. PubMed ID: 12056832
[TBL] [Abstract][Full Text] [Related]
28. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Jäger D; Stockert E; Güre AO; Scanlan MJ; Karbach J; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 2001 Mar; 61(5):2055-61. PubMed ID: 11280766
[TBL] [Abstract][Full Text] [Related]
29. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
[TBL] [Abstract][Full Text] [Related]
30. CABYR is a novel cancer-testis antigen in lung cancer.
Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
[TBL] [Abstract][Full Text] [Related]
31. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
32. Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
Yamada A; Kawano K; Koga M; Takamori S; Nakagawa M; Itoh K
Cancer Res; 2003 Jun; 63(11):2829-35. PubMed ID: 12782588
[TBL] [Abstract][Full Text] [Related]
33. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma.
Diesinger I; Bauer C; Brass N; Schaefers HJ; Comtesse N; Sybrecht G; Meese E
Int J Cancer; 2002 Dec; 102(4):372-8. PubMed ID: 12402307
[TBL] [Abstract][Full Text] [Related]
34. [Serological screening of xenogeneic antigens from rat testis].
Peng F; Tian L; Deng HX; Li Y; Yang HS; Kan B; Zhao X; Liao J; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):305-8. PubMed ID: 15181820
[TBL] [Abstract][Full Text] [Related]
35. [Construction of cDNA library from NPC tissue and screening of antigenic genes].
Shu J; Li GC; He XJ
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):54-8. PubMed ID: 16108490
[TBL] [Abstract][Full Text] [Related]
36. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
37. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.
Shoji M; Kawamoto S; Setoguchi Y; Mochizuki K; Honjoh T; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K
Hum Antibodies Hybridomas; 1994; 5(3-4):123-30. PubMed ID: 7756577
[TBL] [Abstract][Full Text] [Related]
38. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens.
Chen YT; Gure AO; Scanlan MJ
Methods Mol Med; 2005; 103():207-16. PubMed ID: 15542909
[TBL] [Abstract][Full Text] [Related]
39. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
[TBL] [Abstract][Full Text] [Related]
40. [Mapping and expression analysis of a different expression cDNA fragment from lung adenocarcinoma cell line].
Fan H; Li Y; Feng HC; Lü BJ; Fu SB; Zhang GY; Li P
Yi Chuan Xue Bao; 2002 Jun; 29(6):476-80. PubMed ID: 12096622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
